𝔖 Bobbio Scriptorium

✦ LIBER ✦

474 Plasma osteopontin (OPN) predicts hypoxia and response to the hypoxic sensitiser Nimorazole in radiotherapy of head and neck cancer. Results from the randomized DAHANCA 5 trial

✍ Scribed by J. Overgaard; M. Nordsmark; J. Alsner; J.G. Eriksen; M.R. Horsman

Book ID: 118620648
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 161 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90506-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma osteopontin, hypoxia, and respons

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial

✍ Jens Overgaard; Jesper Grau Eriksen; Marianne Nordsmark; Jan Alsner; Michael R H 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 134 KB

A randomized double-blind phase III stud

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish head and neck cancer study (Dahanca) protocol 5–85: Overgaard J, Hansen HS, Overgaard M, Basthold L, Berthelsen A, Specht L, Lindelov B, Jorgensen K Radioth Oncol 1998; 46 : 135–146

📂 Article 📅 1998 🏛 Elsevier Science 🌐 French ⚖ 121 KB